IPP Bureau
PharmaZell and Novasep come together to form a formidable API and CDMO platform
By IPP Bureau - September 17, 2021
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
Canada approves Moderna’s Covid-19 vaccine
By IPP Bureau - September 17, 2021
In the final analysis of Phase 3 COVE study data, SPIKEVAX showed 93% efficacy, with the efficacy remaining durable through six months after the administration of the second dose
Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation
By IPP Bureau - September 17, 2021
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
.jpg "Promising prospects for Indian pharma: CLSA")
Promising prospects for Indian pharma: CLSA
By IPP Bureau - September 17, 2021
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
Machine Learning to understand and prevent disease
By IPP Bureau - September 17, 2021
Barbara Engelhardt moves her computational and statistics lab to Gladstone
Novavax to participate in Oxford university’s study on combining Covid-19 vaccines
By IPP Bureau - September 17, 2021
Study to explore heterologous regimen of COVID-19 vaccines from different manufacturers in adolescents 12-16 years of age
Argenta acquires Klifovet to expand global footprint in animal health
By IPP Bureau - September 17, 2021
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Unum designs vaccine verification tool to track Covid-19 vaccination status
By IPP Bureau - September 17, 2021
It will also manage test result documentation for employees who are not vaccinated, sending weekly reminders and employer notification
Sakra World Hospital opens fertility centre
By IPP Bureau - September 17, 2021
It comes with a prime focus on infection control and patient flow as the primary infrastructure design aspects - the need of the hour and must-have during a pandemic.
DRDO places orders for oxygen generators with 10 companies
By IPP Bureau - September 16, 2021
Godrej and Boyce and Isgec Engineering have confirmed receiving the orders
DGCI gives a go-ahead for Phase III Sputnik Light trials
By IPP Bureau - September 16, 2021
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
Allianz Partners expands its Digital Health Assistant to India
By IPP Bureau - September 16, 2021
Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative
Maharashtra to publicise health tips on social media
By IPP Bureau - September 16, 2021
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
U.S. FDA approves Thermo Fisher Scientific’s Oncomine Dx target test
By IPP Bureau - September 16, 2021
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
Lupin to settle litigations over diabetes drug
By IPP Bureau - September 16, 2021
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
